Subscribe To
SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Nirogacestat for the Treatment of Adults with Desmoid Tumors
STAMFORD, Conn., Dec. 27, 2022 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, announced today that the Company has completed the submission of a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for […] The post SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Nirogacesta...
Read More
Content Topics
Springworks
Therapeutics
Completes
Submission
Drug
Application
Nirogacestat
Treatment
Adults
Desmoid
Tumors
Forex
Posted: Dec 27 2022, 11:30
Author Name: forextv
Views: 091941